Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

Antidepressant Withdrawal Syndrome

No authors listed
, editors.
In: Therapeutics Letter. Vancouver (BC): Therapeutics Initiative; 1994. Letter 112.
2018 Jun.
Free Books & Documents
Review

Antidepressant Withdrawal Syndrome

No authors listed.
Free Books & Documents

Excerpt

Therapeutics Letter 112 examines antidepressant withdrawal syndrome. Conclusions: Antidepressants should be added to the list of drugs associated with tolerance, dependence and a withdrawal syndrome. Withdrawal symptoms occur in at least one-third of patients who stop. Before starting an antidepressant, patients must be informed of the possibility of withdrawal symptoms. The requirements for informed consent are analogous to recommendations before initiating long-term opioid therapy. Some symptoms may improve upon stopping but this is not captured in the studies of antidepressant withdrawal. Any decision to abruptly stop or taper an antidepressant must consider the potential that recurrent depressive symptoms or increased suicidality may represent withdrawal or re-emergence of the original condition.

PubMed Disclaimer

References

    1. Schatzberg AF, Haddad P, Kaplan EMet al. . Serotonin reuptake inhibitor discontinuation syndrome: a hypothetical definition. Discontinuation Consensus panel. J Clin Psychiatry. 1997;58 Suppl 7:5–10. MEDLINE: 9219487 - PubMed
    1. Black K, Shea C, Dursun S, Kutcher S. Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria. J Psychiatry Neurosci. 2000;25(3):255–61. MEDLINE: 10863885 - PMC - PubMed
    1. Schatzberg AF, Haddad P, Kaplan EMet al. . Possible biological mechanisms of the serotonin reuptake inhibitor discontinuation syndrome. Discontinuation Consensus Panel. J Clin Psychiatry. 1997;58 Suppl 7:23–7. MEDLINE: 9219490 - PubMed
    1. Renoir T. Selective serotonin reuptake inhibitor antidepressant treatment discontinuation syndrome: a review of the clinical evidence and the possible mechanisms involved. Front Pharmacol. 2013;4:45. doi: 10.3389/fphar.2013.00045 - DOI - PMC - PubMed
    1. Fava GA, Gatti A, Belaise Cet al. . Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review. Psychother Psychosom. 2015;84(2):72–81. DOI: 10.1159/000370338 - DOI - PubMed

LinkOut - more resources